How fast does Wegovy start to work — and what should you notice first?

What the STEP 1 trial actually shows about the early weeks

The landmark STEP 1 study followed 1,961 adults with obesity over 68 weeks, tracking weight at each visit. The data tells a consistent story: the appetite-suppressing effect of semaglutide arrives early, but weight loss is a lagging indicator. Participants started at 0.25mg (a dose designed to let the body adjust, not to produce rapid loss) and the scale reflected that. By weeks four to eight, once the dose had moved to 0.5mg and then 1mg, average losses began to accumulate. The steepest rate of loss in the trial tended to fall between weeks eight and roughly 36, when doses were climbing toward the 2.4mg ceiling. After that, the curve flattens as the body reaches a new set point.

That trajectory matters practically. If you weigh yourself on day five and see nothing, that's expected. The medicine is working on your hunger and fullness signals before those changes show up in kilograms. Month two is often when patients first feel the treatment is 'clicking', appetite noticeably lower, portion sizes naturally smaller, energy steadier.

The NHS semaglutide medicines page notes that common gastrointestinal effects (nausea, indigestion, occasional vomiting) are most pronounced in the first few weeks after starting or after a dose increase. Many people find these settle within a fortnight. That initial discomfort can sometimes be mistaken for the treatment failing, when it is actually a sign the medicine is active.

The titration schedule and why patience pays off

Wegovy's five-step dose ladder (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) isn't arbitrary. Each step lasts roughly four weeks, giving your gut time to adapt and your prescriber time to review your response. At 0.25mg the primary goal is tolerability; therapeutic weight loss is a secondary effect at that stage. The real momentum builds from 1mg upward.

This is worth sitting with if you're in your first month and feel frustrated. If you're curious about how fast Wegovy works and what drives those early changes, the short answer is that the appetite effects come first and the scale follows. The titration exists precisely because pushing to 2.4mg immediately would produce more side effects without proportionally faster results.

If you want a fuller picture of how long Wegovy takes to produce results across the full treatment period, that's worth reading alongside this page. And if you're weighing up how Wegovy's timeline compares with tirzepatide's, our treatment overview sets out the options clearly.

Factors that shape your personal timeline

Trial averages describe a population, not a person. Several things influence how quickly Wegovy works for any individual. Starting body weight is one: people with higher starting BMIs often see larger absolute losses but may feel the percentage shift more slowly at first. Metabolic rate, insulin sensitivity, how closely someone follows a reduced-calorie diet alongside the injection, and their activity level all play a role. Adherence to the titration schedule also matters, missing doses or pausing treatment resets some of the appetite adaptation.

Sleep, stress and whether any underlying conditions (such as hypothyroidism) are well managed can all affect the rate of progress too. None of this is a reason to be disheartened; it's a reason to treat the titration period as a calibration phase rather than a waiting room. If you're considering the cost side of a full course, the Wegovy cost context page explains what a transparent private price covers.

For anyone curious about how long Wegovy takes to start working, including what to expect at each stage of the dose increase, our page on semaglutide's onset goes into the mechanism in more detail. If you'd like to understand how fast Wegovy starts working once your first dose is given, that page walks through the earliest changes you can reasonably expect to notice.

Signs the treatment is working, and when to flag something

Concrete early signals that Wegovy is active include: reduced hunger between meals, feeling full more quickly when eating, fewer cravings for high-calorie foods, and sometimes a slight nausea after injection. These are pharmacological effects, not coincidence. Scale progress usually follows within a few weeks of those appetite changes becoming consistent.

If after 12 weeks at a stable dose you're seeing no weight movement at all, that's worth raising with your prescriber rather than adjusting the dose yourself. Equally, NICE guidance on semaglutide (published as TA875) recommends considering whether to continue if less than 5% weight loss has occurred after six months at the maintenance dose. That review is a clinical conversation, not an automatic stop.

Severe, persistent stomach pain that radiates to the back needs prompt medical attention, acute pancreatitis is a known but infrequent side effect of GLP-1 medicines, and the MHRA highlighted it in a 2026 Drug Safety Update. Any suspected side effect can be reported at the MHRA's Yellow Card scheme. Wegovy is a prescription-only medicine and ongoing clinical oversight is part of how safe treatment works, not an add-on to it.